|Articles|October 13, 2020
Can a Two-Step Process Be an Effective Monoclonal Antibody Purification Platform?
Author(s)Tosoh Bioscience
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Executive Summary: From Molecule to Formulation: A Systematic Approach to Assess Biologics Developability
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
Generative AI and Adaptive Trials Shape Future Biotech Development
5